↓ Skip to main content

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

Overview of attention for article published in Trials, August 2020
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
92 X users
patent
2 patents
facebook
1 Facebook page

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
275 Mendeley
Title
Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial
Published in
Trials, August 2020
DOI 10.1186/s13063-020-04647-x
Pubmed ID
Authors

Abdulrahman E. Koshak, Emad A. Koshak, Abdullah F. Mobeireek, Mazen A. Badawi, Siraj O. Wali, Husam M. Malibary, Ali F. Atwah, Meshari M. Alhamdan, Reem A. Almalki, Tariq A. Madani

X Demographics

X Demographics

The data shown below were collected from the profiles of 92 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 275 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 275 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 35 13%
Student > Master 26 9%
Researcher 23 8%
Student > Ph. D. Student 18 7%
Other 14 5%
Other 44 16%
Unknown 115 42%
Readers by discipline Count As %
Medicine and Dentistry 55 20%
Nursing and Health Professions 29 11%
Pharmacology, Toxicology and Pharmaceutical Science 15 5%
Biochemistry, Genetics and Molecular Biology 7 3%
Psychology 6 2%
Other 34 12%
Unknown 129 47%